All In MedTech

Device Trial Radar · NCT05559567

Axial Length With Adult Onset Myopia (ALWAOM)

Axial Length With Adult Onset Myopia

Last checked: Nov 20, 2026Latest source record: Aug 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

Sep 1, 2023

Primary completion

May 2025

Study completion Aug 2025

Sponsor

Lead sponsor
Art Optical Contact Lens, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
University of Missouri, St. Louis
First posted
Sep 29, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 21 years, up to 35 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Purpose: To determine axial length progression and its relationship with myopia onset and progression in adults.

Conditions

  • Myopia

Interventions

  • OrthokeratologyDevice

    The use of a specialty GP contact lens to temporarily correct myopia

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Axial Length progressionTime frame: Two years

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Missouri-St. Louis College of Optometry

    St Louis, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.